Truncated YY1 interacts with BASP1 through a 339KLK341 motif in YY1 and suppresses vascular smooth muscle cell growth and intimal hyperplasia after vascular injury.

Santiago, Fernando S.; Li, Yue; Zhong, Ling; Raftery, Mark J.; Lins, Laurence; Khachigian, Levon M.

doi:10.1093/cvr/cvab021

Article (Scientific journals)

Truncated YY1 interacts with BASP1 through a 339KLK341 motif in YY1 and suppresses vascular smooth muscle cell growth and intimal hyperplasia after vascular injury.

Santiago, Fernando S.; Li, Yue; Zhong, Ling et al.

2021 • In Cardiovascular Research

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/261258

DOI
10.1093/cvr/cvab021

PubMed
33508088

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Levoncvab2021.pdf

Publisher postprint (1.08 MB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

BASP1; YY1; endothelial cells; mass spectrometry; smooth muscle cells

Abstract :

[en] AIMS: In-stent restenosis and late stent thrombosis are complications associated with the use of metallic and drug-coated stents. Strategies that inhibit vascular smooth muscle cell (SMC) proliferation without affecting endothelial cell (EC) growth would be helpful in reducing complications arising from percutaneous interventions. Our group previously showed that the forced expression of the injury-inducible zinc finger (ZNF) transcription factor, yin yang-1 (YY1) comprising 414 residues inhibits neointima formation in carotid arteries of rabbits and rats. YY1 inhibits SMC proliferation without affecting EC growth. Identifying a shorter version of YY1 retaining cell-selective inhibition would make it more amenable for potential use as a gene therapeutic agent. METHODS AND RESULTS: We dissected YY1 into a range of shorter fragments (YY1A-D, YY1Δ) and found that the first two ZNFs in YY1 (construct YY1B, spanning 52 residues) repressed SMC proliferation. Receptor Binding Domain analysis predicts a three residue (339KLK341) interaction domain. Mutation of 339KLK341 to 339AAA341 in YY1B (called YY1Bm) abrogated YY1B's ability to inhibit SMC but not EC proliferation and migration. Incubation of recombinant GST-YY1B and GST-YY1Bm with SMC lysates followed by precipitation with glutathione-agarose beads and mass spectrometric analysis identified a novel interaction between YY1B and BASP1. Overexpression of BASP1, like YY1, inhibited SMC but not EC proliferation and migration. BASP1 siRNA partially rescued SMC from growth inhibition by YY1B. In the rat carotid balloon injury model, adenoviral overexpression of YY1B, like full-length YY1, reduced neointima formation, whereas YY1Bm had no such effect. CD31 immunostaining suggested YY1B could increase re-endothelialization in a 339KLK341-dependent manner. CONCLUSIONS: These studies identify a truncated form of YY1 (YY1B) that can interact with BASP1 and inhibits SMC proliferation, migration and intimal hyperplasia after balloon injury of rat carotid arteries as effectively as full length YY1. We demonstrate the therapeutic potential of YY1B in vascular proliferative disease.

Disciplines :

Biochemistry, biophysics & molecular biology

Author, co-author :

Santiago, Fernando S.

Li, Yue

Zhong, Ling

Raftery, Mark J.

Lins, Laurence ; Université de Liège - ULiège > Département GxABT > Chimie des agro-biosystèmes

Khachigian, Levon M.

Language :

English

Title :

Truncated YY1 interacts with BASP1 through a 339KLK341 motif in YY1 and suppresses vascular smooth muscle cell growth and intimal hyperplasia after vascular injury.

Publication date :

2021

Journal title :

Cardiovascular Research

ISSN :

0008-6363

eISSN :

1755-3245

Publisher :

Elsevier, Netherlands

Peer reviewed :

Peer Reviewed verified by ORBi

Commentary :

Available on ORBi :

since 22 June 2021

Statistics

Number of views

75 (4 by ULiège)

Number of downloads

1 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Thomas MJ, Seto E. Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? Gene 1999;236:197-208.
Bushmeyer S, Park K, Atchison ML. Characterization of functional domains within the multifunctional transcription factor, YY1. J Biol Chem 1995;270:30213-30220.
Schug J, Schuller WP, Kappen C, Salbaum JM, Bucan M, Stoeckert CJ Jr. Promoter features related to tissue specificity as measured by Shannon entropy. Genome Biol 2005;6:R33.
Lee J-S, Galvin KM, Shi Y. Evidence for physical interaction between the zinc-finger transcription factors YY1 and Sp1. Proc Natl Acad Sci USA 1993;90: 6145-6149.
Santiago FS, Ishii H, Shafi S, Khurana R, Kanellakis P, Bhindi R, Ramirez M, Bobik A, Martin J, Chesterman CN, Zachary I, Khachigian L. Yin Yang-1 inhibits intimal thickening by repressing p21WAF1/Cip1 transcription and p21WAF1/Cip1-Cdk4-Cyclin D1 assembly. Circ Res 2007;101:146-155.
Luke MP, Sui G, Liu H, Shi Y. Yin Yang 1 physically interacts with Hoxa11 and represses Hoxa11-dependent transcription. J Biol Chem 2006;281: 33226-33232.
Yao YL, Yang WM, Seto E. Regulation of transcription factor YY1 by acetylation and deacetylation. Mol Cell Biol 2001;21:5979-5991.
Margolis DM, Somasundaran M, Green MR. Human transcription factor YY1 represses human immunodeficiency virus type 1 transcription and Virion production. J Virol 1994;68:905-910.
Coull JJ, Romerio F, Sun J-M, Volker JL, Galvin KM, Davie JR, Shi Y, Hansen U, Margolis DM. The human factors YY1 and LSK repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1. J Virol 2000;74:6790-6799.
Yu KL, Jung YM, Park SH, Lee SD, You JC. Human transcription factor YY1 could upregulate the HIV-1 gene expression. BMB Rep 2020;53:248-253.
Khachigian LM. The Yin and Yang of YY1 in tumor growth and suppression. Int J Cancer 2018;143:460-465.
Anwar S, Vachharajani TJ. Stent use for hemodialysis access: what a general nephrologist needs to know. Hemodial Int 2018;22:143-149.
Li Y, Bhindi R, Khachigian LM. Recent developments in drug-eluting stents. J Mol Med 2011;89:545-553.
Lowe HC, Oesterle SN, Khachigian LM. Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol 2002;39:183-193.
Mintz GS, Popma JJ, Hong MK, Pichard AD, Kent KM, Satler LF, Leon MB. Intravascular ultrasound to discern device-specific effects and mechanisms of restenosis. Am J Cardiol 1996;78:18-22.
Sukhija R, Aronow WS, Sureddi R, Aleti S, Molavi B, Sachdeva R, Mehta JL. Predictors of in-stent restenosis and patient outcome after percutaneous coronary intervention in patients with diabetes mellitus. Am J Cardiol 2007;100:777-780.
Santiago FS, Lowe HC, Bobryshev YV, Khachigian LM. Induction of the transcriptional repressor Yin Yang-1 by vascular cell injury: autocrine/paracrine role of endogenous fibroblast growth factor-2. J Biol Chem 2001;276:41143-41149.
Jin M, Wu Y, Wang Y, Yu D, Yang M, Yang F, Feng C, Chen T. MicroRNA-29a promotes smooth muscle cell differentiation from stem cells by targeting YY1. Stem Cell Res 2016;17:277-284.
Zhang Y, Li YH, Liu C, Nie CJ, Zhang XH, Zheng CY, Jiang W, Yin WN, Ren MH, Jin YX, Liu SF, Zheng B, Wen JK. miR-29a regulates vascular neointimal hyperplasia by targeting YY1. Cell Prolif 2017;50:e12322.
Beck K, Wu BJ, Ni J, Santiago FS, Malabanan KP, Li C, Wang Y, Khachigian LM, Stocker R. Interplay between heme oxygenase-1 and the multifunctional transcription factor yin yang 1 in the inhibition of intimal hyperplasia. Circ Res 2010;107: 1490-1497.
Tillotson R, Selfridge J, Koerner MV, Gadalla KKE, Guy J, De Sousa D, Hector RD, Cobb SR, Bird A. Radically truncated MeCP2 rescues Rett syndrome-like neurological defects. Nature 2017;550:398-401.
Wang B, Li J, Xiao X. Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model. Proc Natl Acad Sci USA 2000;97:13714-13719.
Watchko J, O'Day T, Wang B, Zhou L, Tang Y, Li J, Xiao X. Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice. Hum Gene Ther 2002;13:1451-1460.
Widmer F, Caroni P. Identification, localization, and primary structure of CAP-23, a particle-bound cytosolic protein of early development. J Cell Biol 1990;111: 3035-3047.
Maekawa S, Maekawa M, Hattori S, Nakamura S. Purification and molecular cloning of a novel acidic calmodulin binding protein from rat brain. J Biol Chem 1993;268: 13703-13709.
Gallet X, Charloteaux B, Thomas A, Brasseur R. A fast method to predict protein interaction sites from sequences. J Mol Biol 2000;302:917-926.
Lobbestael E, Reumers V, Ibrahimi A, Paesen P, Thiry I, Gijsbers R, van den Haute C, Debyser Z, Baekelandt V, Taymans JM. Immunohistochemical detection of transgene expression in the brain using small epitope tags. BMC Biotechnol 2010;10:16.
Yang C, Danielson EW, Qiao T, Metterville J, Brown RH, Landers JE, Xu Z. Mutant PFN1 causes ALS phenotypes and progressive motor neuron degeneration in mice by a gain of toxicity. Proc Natl Acad Sci USA 2016;113:E6209-E6218.
Zhou Q, Gedrich RW, Engel DA. Transcriptional repression of the c-fos gene by YY1 is mediated by a direct interaction with ATF/CREB. J Virol 1995;69:4323-4330.
Pastoret S, Fraipont C, den Blaauwen T, Wolf BT, Aarsman Mirjam EG, Piette A, Thomas A, Brasseur R, Nguyen-Disteche M, Functional analysis of the cell division protein FtsW of Escherichia coli. J Bacteriol 2004;186:8370-8379.
Renauld-Mongénie G, Lins L, Krell T, Laffly L, Mignon M, Dupuy M, Delrue R-M, Guinet-Morlot F, Brasseur R, Lissolo L. Transferrin-binding protein B of Neisseria meningitidis: sequence-based identification of the transferrin-Binding site confirmed by site-directed mutagenesis. J Bacteriol 2004;186:850-857.
Irshad Z, Xue M, Ashour A, Larkin JR, Thornalley PJ, Rabbani N. Activation of the unfolded protein response in high glucose treated endothelial cells is mediated by methylglyoxal. Sci Rep 2019;9:7889.
Toska E, Shandilya J, Goodfellow S, Medler K, Roberts S. Prohibitin is required for transcriptional repression by the WT1-BASP1 complex. Oncogene 2014;33:5100-5108.
Fogar P, Navaglia F, Basso D, Zambon C-F, Moserle L, Indraccolo S, Stranges A, Greco E, Fadi E, Padoan A, Pantano G, Sanzari MC, Pedrazzoli S, Montecucco C, Plebani M. Heat-induced transcription of diphtheria toxin A or its variants, CRM176 and CRM197: implications for pancreatic cancer gene therapy. Cancer Gene Ther 2010;17:58-68.
Chan JM, Rhee JW, Drum CL, Bronson RT, Golomb G, Langer R, Farokhzad OC. In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles. Proc Natl Acad Sci USA 2011;108:19347-19352.
Signore PE, Machan LS, Jackson JK, Burt H, Bromley P, Wilson JE, McManus BM. Complete inhibition of intimal hyperplasia by perivascular delivery of paclitaxel in balloon-injured rat carotid arteries. J Vasc Interv Radiol 2001;12:79-88.
Ward MR, Pasterkamp G, Yeung AC, Borst C. Arterial remodeling: mechanisms and clinical implications. Circulation 2000;102:1186-1191.
Houbaviy HB, Usheva A, Shenk T, Burley SK. Cocrystal structure of YY1 bound to the adeno-associated virus P5 initiator. Proc Natl Acad Sci USA 1996;93:13577-13582.
Austen M, Luscher B, Luscher-Firzlaff JM. Characterization of the transcriptional regulator YY1: the bipartite transactivation domain is independent of interaction with the TATA box-binding protein, transcription factor IIB, TAFII55, or cAMP-responsive element-binding protein (CPB)-binding protein. J Biol Chem 1996;272:1709-1717.
Diaz-Meco MT, Municio MM, Sanchez P, Lozano J, Moscat J. Lambda-interacting protein, a novel protein that specifically interacts with the zinc finger domain of the atypical protein kinase C isotype lambda/iota and stimulates its kinase activity in vitro and in vivo. Mol Cell Biol 1996;16:105-114.
Yoo YD, Chiou CJ, Choi KS, Yi Y, Michelson S, Kim S, Hayward GS, Kim SJ. The IE2 regulatory protein of human cytomegalovirus induces expression of the human transforming growth factor beta1 gene through an Egr-1 binding site. J Virol 1996;70:7062-7670.
Hung HL, Lau J, Kim AY, Weiss MJ, Blobel GA. CREB-binding protein acetylates hematopoietic transcription factor GATA-1 at functionally important sites. Mol Cell Biol 1999;19:3496-3505.
Lee A, CingOz O, Sabo Y, Goff SP. Characterization of interaction between Trim28 and YY1 in silencing proviral DNA of Moloney murine leukemia virus. Virology 2018; 516:165-175.
Wai DC, Shihab M, Low JK, Mackay JP. The zinc fingers of YY1 bind single-stranded RNA with low sequence specificity. Nucleic Acids Res 2016;44:9153-9165.
Garg R, Tellez A, Alviar C, Granada J, Kleiman NS, Lev EI. The effect of percutaneous coronary intervention on inflammatory response and endothelial progenitor cell recruitment. Cathet Cardiovasc Intervent 2008;72:205-209.
Gimbrone MA, Garciá-Cardeña G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res 2016;118:620-636.
Marsh LA, Carrera S, Shandilya J, Heesom KJ, Davidson AD, Medler KF, Roberts SG. BASP1 interacts with oestrogen receptor alpha and modifies the tamoxifen response. Cell Death Dis 2017;8:e2771-e2771.
Yang L, Han Y, Saurez Saiz F, Minden MD. A tumor suppressor and oncogene: the WT1 story. Leukemia 2007;21:868-876.
Carpenter B, Hill KJ, Charalambous M, Wagner KJ, Lahiri D, James DI, Andersen JS, Schumacher V, Royer-Pokora B, Mann M, Ward A, Roberts SG. BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1. MCB 2004;24: 537-549.
Tian Z, Sun Y, Sun X, Wang J, Jiang T. LINC00473 inhibits vascular smooth muscle cell viability to promote aneurysm formation via miR-212-5p/BASP1 axis. Eur J Pharmacol 2020;873:172935.
Corpet F. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res 1988;16:10881-10890.
He Y, Casaccia-Bonnefil P. The Yin and Yang of YY1 in the nervous system. J Neurochem 2008;106:1493-1502.
Atchison ML. Function of YY1 in long-distance DNA interactions. Front Immunol 2014;5:45.
Rizkallah R, Hurt MM. The multilayered regulation of the oncogenic protein YY1. Crit Rev Oncog 2017;22:109-129.
Kim JD, Faulk C, Kim J. Retroposition and evolution of the DNA-binding motifs of YY1, YY2 and REX1. Nucleic Acids Res 2007;35:3442-3452.
Shi Y, Lee JS, Galvin KM. Everything you have ever wanted to know about Yin Yang 1. Biochim Biophys Acta 1997;1332:F49-F66.
Zhang WJ, Wu XN, Shi TT, Xu HT, Yi J, Shen HF, Huang MF, Shu XY, Wang FF, Peng BL, Xiao RQ, Gao WW, Ding JC, Liu W. Regulation of transcription factor Yin Yang 1 by SET7/9-mediated lysine methylation. Sci Rep 2016;6:21718.